Quantum Cyber N.V. current report, Q3 FY2022

SEC Filing Summary: Mainz Biomed N.V. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Mainz Biomed N.V. (not Quantum Cyber N.V.) for the month of September 2022, with the report date of September 28, 2022. The registrant is a foreign private issuer headquartered in Mainz, Germany.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial statements or performance data.

Material Changes

The primary material event reported is the Company's intention to call an Extraordinary General Meeting during the week of December 12, 2022. The purpose of this meeting is to vote on the nomination of two new individuals to the Board of Directors:

  • Dr. Heiner Dreismann
  • Mr. Gregory Tibbitts

Guidance, Outlook, and Risks

The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the upcoming board nomination vote.

Key Facts for Investor Verification

  • Verify the exact date and agenda of the Extraordinary General Meeting scheduled for the week of December 12, 2022.
  • Confirm the qualifications and background of the nominees, Dr. Heiner Dreismann and Mr. Gregory Tibbitts.
  • Review the attached press release (Exhibit 99.1) for additional details on the board strengthening strategy.
  • Note that this filing contains no financial performance data for the period.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.